NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

And this is "faster" from the efficacy NWBO expected for phase 1 results?

From their PR on 9/24/13

The primary endpoint of the trial for measuring the efficacy of DCVax-Direct is tumor regression. Since regression may be seen within just a few months of treatment, and since this Phase I/II trial is an open label, unblinded trial, it is anticipated that some initial results from the first patients may be seen before year end.

Don't worry, they didn't forget to use their favorite word "anticipated."